Showing results (81-90 of 163) with videos related to
Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|December 12, 2007
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluationAlessandra Fabi, Giulio Metro, Paola Papaldo, et al.Journal of Breast Cancer|October 11, 2016
Ductal Breast Carcinoma Metastatic to the Stomach Resembling Primary Linitis Plastica in a Male PatientBiagio Ricciuti, Giulia Costanza Leonardi, Noemi Ravaioli, et al.Lung Cancer (Amsterdam, Netherlands)|July 10, 2012
Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotypeGiulio Metro, Rita Chiari, Simona Duranti, et al.Expert Opinion on Drug Safety|December 3, 2016
The safety of nivolumab for the treatment of advanced non-small cell lung cancerGiulio Metro, Biagio Ricciuti, Marta Brambilla, et al.BMC Cancer|April 2, 2009
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylationAlessandra Fabi, Giulio Metro, Michelangelo Russillo, et al.Clinical Lung Cancer|October 22, 2013
Clinical outcome with platinum-based chemotherapy in patients with advanced nonsquamous EGFR wild-type non-small-cell lung cancer segregated according to KRAS mutation statusGiulio Metro, Rita Chiari, Chiara Bennati, et al.Diagnostics (Basel, Switzerland)|December 10, 2020
Detection of <i>EGFR</i> Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCRAnnamaria Siggillino, Paola Ulivi, Luigi Pasini, et al.Translational Oncology|July 2, 2022
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutationsMatteo Canale, Elisabetta Petracci, Paola Cravero, et al.Cancer Chemotherapy and Pharmacology|October 23, 2009
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiformeGiulio Metro, Alessandra Fabi, Maria A Mirri, et al.Frontiers in Oncology|September 25, 2020
Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer PatientsChristian Britschgi, Alfredo Addeo, Markus Rechsteiner, et al.Pageof 17